Quotient Sciences Quotient Sciences

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Digital content for BioCryst Pharmaceuticals

    Client Virtual Booth

    BIOCRYST PHARMACEUTICALS

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Formulations

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    BioCryst Pharmaceuticals
    United_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    4505 Emperor Blvd., Suite 200 Durham, NC 27703
    Telephone
    Telephone
    (919) 859-1302
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.biocryst.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/biocryst-pharmaceuticals/
    Twitter
    Twitter
    https://twitter.com/biocrystpharma?lang=en

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    BioCryst's ORLADEYO Approved in Brazil
    BioCryst's ORLADEYO Approved in Brazil

    https://www.globenewswire.com/news-release/2024/04/17/2864299/29446/en/BioCryst-Announces-Approval-of-ORLADEYO-berotralstat-by-the-Brazilian-Health-Regulatory-Agency.html

    GLOBENEWSWIRE
    17 Apr 2024
    Share Share
    BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    https://www.globenewswire.com/news-release/2024/04/03/2856796/29446/en/BioCryst-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html

    GLOBENEWSWIRE
    03 Apr 2024
    Share Share
    BioCryst to Present at Upcoming Investor Conferences
    BioCryst to Present at Upcoming Investor Conferences

    https://www.globenewswire.com/news-release/2024/03/25/2851977/29446/en/BioCryst-to-Present-at-Upcoming-Investor-Conferences.html

    GLOBENEWSWIRE
    25 Mar 2024
    Share Share
    BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    https://www.globenewswire.com//news-release/2024/03/05/2840296/29446/en/BioCryst-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html

    GLOBENEWSWIRE
    05 Mar 2024
    Share Share
    BioCryst Reports Fourth Quarter and Full Year 2023 Financial Results
    BioCryst Reports Fourth Quarter and Full Year 2023 Financial Results

    https://www.globenewswire.com//news-release/2024/02/26/2834990/29446/en/BioCryst-Reports-Fourth-Quarter-and-Full-Year-2023-Financial-Results-and-Upcoming-Key-Milestones.html

    GLOBENEWSWIRE
    26 Feb 2024
    Share Share
    BioCryst Presents Data Showing HAE Attack Reductions After Beginning ORLADEYO
    BioCryst Presents Data Showing HAE Attack Reductions After Beginning ORLADEYO

    https://www.globenewswire.com//news-release/2024/02/23/2834384/29446/en/BioCryst-Presents-New-Real-world-Data-Showing-Rapid-Substantial-and-Sustained-HAE-Attack-Rate-Reductions-After-Beginning-ORLADEYO-berotralstat-Treatment.html

    GLOBENEWSWIRE
    23 Feb 2024
    Share Share
    BioCryst to Present at Upcoming Investor Conferences
    BioCryst to Present at Upcoming Investor Conferences

    https://www.globenewswire.com//news-release/2024/02/21/2833105/29446/en/BioCryst-to-Present-at-Upcoming-Investor-Conferences.html

    GLOBENEWSWIRE
    21 Feb 2024
    Share Share
    BioCryst Launches ORLADEYO® (berotralstat) in Italy
    BioCryst Launches ORLADEYO® (berotralstat) in Italy

    https://www.globenewswire.com//news-release/2024/02/19/2831256/29446/en/BioCryst-Launches-ORLADEYO-berotralstat-in-Italy.html

    GLOBENEWSWIRE
    19 Feb 2024
    Share Share
    BioCryst to Report Fourth Quarter 2023 Financial Results on February 26
    BioCryst to Report Fourth Quarter 2023 Financial Results on February 26

    https://www.globenewswire.com//news-release/2024/02/12/2827415/29446/en/BioCryst-to-Report-Fourth-Quarter-2023-Financial-Results-on-February-26.html

    GLOBENEWSWIRE
    12 Feb 2024
    Share Share
    BioCryst to Present New ORLADEYO® (berotralstat) Real-world Data
    BioCryst to Present New ORLADEYO® (berotralstat) Real-world Data

    https://www.globenewswire.com//news-release/2024/02/05/2823391/29446/en/BioCryst-to-Present-New-ORLADEYO-berotralstat-Real-world-Data-at-2024-American-Academy-of-Allergy-Asthma-Immunology-Annual-Meeting.html

    GLOBENEWSWIRE
    05 Feb 2024
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    polpharma-m-2024-04-15

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search